This Event has Passed
- Virtual
Blood Biomarkers in Dementia: From Research to Clinical Use
Learn more about STAT Brand Studio and partner with us for your next event!
Where
Virtual
When
{{getUserDateTimezone("1718290800").singleDate}}
{{getUserDateTimezone("1718290800").time}} - {{getUserDateTimezone("1718292600").time}} {{getClientTimezoneName()}}
About
Blood biomarkers are transforming research and clinical care for dementia, Alzheimer’s, and other neurodegenerative diseases. We’ll explore their evolution, from global proteomics to disease-specific markers such as p-tau, GFAP, and amyloid-beta. The session will focus on the utility of plasma p-Tau 217, and will look to future possibilities — including remote testing and emerging markers — to further highlight biomarkers’ role in improving dementia diagnosis and treatment.
Moderator
Jesse McQuarters, Branded Content Editor at STAT
Speakers
Nicholas Ashton, Ph.D., Associate Professor, University of Gothenburg
After receiving his Ph.D. from King’s College, Dr. Ashton joined the University of Gothenburg, where he has made major contributions to the development and use of biofluid assays for Alzheimer’s disease and related disorders. One of the most highly cited researchers, he has published more than 200 articles and, in 2021, received the Queen Silvia Prize for a Young Alzheimer’s Researcher.
In Partnership with
STAT editorial staff were not involved in the creation or execution of this event.
Upcoming Events
The immune-checkpoint inhibitor market alone was worth $15.5B in 2023. But could new diagnostics help it exceed its $53.5B predicted value i…